2011
DOI: 10.1111/j.1365-2133.2011.10315.x
|View full text |Cite
|
Sign up to set email alerts
|

Varicella-zoster virus immunity in dermatological patients on systemic immunosuppressant treatment

Abstract: The prevalence of VZV IgG antibodies in our cohort of Irish dermatology patients receiving immunosuppressive therapy is 98·7%. A recalled history of varicella infection is a good predictor of serological immunity. This study has shown that there are VZV-susceptible individuals within our cohort. These patients did not have a clear history of previous infection. We recommend serological testing of patients without a clear history of infection prior to the commencement of immunosuppressive therapy and vaccinatio… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
4
0
1

Year Published

2011
2011
2019
2019

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(5 citation statements)
references
References 11 publications
0
4
0
1
Order By: Relevance
“…VZIG, however, cannot completely prevent the people exposed to VZV from developing varicella as in our case, and it might prolong the incubation period of the virus by one week. Therefore, clinicians should carefully monitor whether the people who receive VZIG may develop varicella for at least four weeks 8,9 …”
Section: Discussionmentioning
confidence: 99%
“…VZIG, however, cannot completely prevent the people exposed to VZV from developing varicella as in our case, and it might prolong the incubation period of the virus by one week. Therefore, clinicians should carefully monitor whether the people who receive VZIG may develop varicella for at least four weeks 8,9 …”
Section: Discussionmentioning
confidence: 99%
“…anzupassen. Hämatologisch-onkologische Erfahrungen deuten darauf hin, dass durch Impfungen Infekte bei immunsupprimierten Patienten verhindert werden können [80][81][82][83][84][85][86]. Hier ist u. a. an Influenza, Hepatitis B, Varizella-Zoster-Virus, Pneumokokkenmeningitis, DPT (Diphterie, Pertussis, Tetanus) zu denken.…”
Section: Einschlusskriterienunclassified
“…Encephalitis is an uncommon complication of varicella zoster virus (VZV) infection in immunocompetent population. However, immunocompromised patients, individuals with autoimmune diseases and patients on immunosuppression have increased vulnerability to VZV dissemination, thus increasing morbidity and mortality [1,2].…”
Section: Introductionmentioning
confidence: 99%
“…Frequently, the patient's clinical symptoms are initially attributed to other etiologies and the therapeutic window of opportunity is lost before the definitive diagnosis can be established. At our medical center, we treated a patient with suspicion of encephalitis based on clinical features and CSF (cerebrospinal fluid) findings supported the diagnosis of VZV which led to timely intervention [2].…”
Section: Introductionmentioning
confidence: 99%